Company News

Share this article:

GlaxoSmithKline announced that it will form a joint venture with China-based Jiangsu Walvax Biotech Company to develop pediatric vaccines for measles, mumps and rubella in China. GSK is investing $29.7 million in the deal initially, and will invest an additional $10.7 million in 2015, according to a company statement.

EMD Serono Canada tapped Ariad Healthcare to market its probiotic multivitamin Multibionta – the number one selling multivitamin in France and the UK – in Canada. Other partners on the assignment include Rao Barrett & Welsh, Environics and M2 Universal.


Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations -- which have been piling up -- have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.